MELANIE RANSOM: Open Payments
NPI 1629658810 · MEDFORD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,964 in 76 payments from 21 companies in 2025. Trend: 2023 $726 · 2024 $1,183 · 2025 $1,964
Food & beverage: $1,865Education: $99
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 10 | $565 |
| GENZYME CORPORATION | 17 | $462 |
| Genentech USA, Inc. | 9 | $149 |
| Optinose US, Inc. | 5 | $141 |
| ARS Pharmaceuticals Operations, Inc. | 7 | $124 |
| SANOFI-AVENTIS U.S. LLC | 1 | $99 |
| Regeneron Healthcare Solutions, Inc. | 4 | $70 |
| Novartis Pharmaceuticals Corporation | 3 | $67 |
| Grifols USA, LLC | 3 | $56 |
| Lilly USA, LLC | 2 | $37 |
Products named: DUPIXENT, AIRSUPRA, Xolair, Xhance, NEFFY, EBGLYSS, Xembify, Ryaltris.
Industry payments across NJ — which companies pay providers there.
